ARTICLE | Company News
CuraGen board of directors update
June 27, 2005 7:00 AM UTC
CuraGen Corp. (CRGN), New Haven, Conn. Business: Cancer, Inflammation, Endocrine Appointed: Michael Astrue, former president and CEO of Transkaryotic Therapies Inc.; and Frank Armstrong, CEO of Bioacc...